2017 Archive

Read how experts came together to create surveillance recommendations for children and young adults with hereditary conditions that predispose them to cancer.

Discover how St. Jude is helping cancer survivors manage the long-term effects of treatment and set up screening guidelines for those still in treatment.

St. Jude honors its patients, survivors and their families during the month of September and every day. Watch the video.

The CSTN provides the world’s largest collection of pediatric cancerous tumors for research into novel treatments. Find out more about available resources.

The FDA has approved Kymriah, the first CAR T-cell therapy for acute lymphoblastic leukemia. Find out how St. Jude is planning to use this novel treatment.

Find out what makes St. Jude Children’s Research Hospital the best pediatric cancer hospital in the nation.

Find out how a newly discovered protein can give your body’s doomed cells a second chance at life.

St. Jude scientists, in work published in the journal Neuron, used powerful analytical tools to map what is known as the “epigenetics” of the retina.

Is Ptpn6, a controlling gene, linked with the master immune switch IL-1 alpha? Can this link be mapped to help pinpoint immune system response? Find out more.

Find out how Trinity uses yoga and make-believe creatures to regain her strength and coordination after pineoblastoma, a type of childhood cancer.